Rech, Andrew J.
Hospital of the University of Pennsylvania · Parker Institute for Cancer Immunotherapy
3 papers on CoChatORCID 0000-0002-6585-8839
Most cited papers
- Verified
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Twyman-Saint Victor, C., Rech, A. J., Maity, A., Rengan, R., Pauken, K. E., Stelekati, E., Benci, J. L., Xu, B., Dada, H., Odorizzi, P. M., et al. (2015) · Nature
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 2,434
- Verified
Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction
Wells, D. K., van Buuren, M. M., Dang, K. K., Hubbard-Lucey, V. M., Sheehan, K. C. F., Campbell, K. M., Lamb, A., Ward, J. P., Sidney, J., Blazquez, A. B., et al. (2020) · Cell
vaccines and immunoinformatics approachesCancer Immunotherapy and Biomarkers
Cited by 538
- Verified
Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for α-1-antitrypsin deficiency
Calcedo, R., Somanathan, S., Qin, Q., Betts, M. R., Rech, A. J., Vonderheide, R. H., Mueller, C., Flotte, T. R., & Wilson, J. M. (2017) · Proceedings of the National Academy of Sciences
Virus-based gene therapy researchImmunotherapy and Immune Responses
Cited by 79
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free